• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒感染相关的原发性肝癌发病率:日本大阪的一项相关性研究。

Primary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan.

作者信息

Tanaka H, Hiyama T, Okubo Y, Kitada A, Fujimoto I

机构信息

Department of Field Research, Center for Adult Diseases, Osaka, Japan.

出版信息

Cancer Causes Control. 1994 Jan;5(1):61-5. doi: 10.1007/BF01830727.

DOI:10.1007/BF01830727
PMID:7510133
Abstract

Osaka, Japan, has one of the highest, primary liver cancer (PLC) incidence-rates in the world, although hepatitis-B virus (HBV) is not endemic. This paper addresses the question of whether the PLC-incidence variation within Osaka Prefecture is due to differences in the prevalence of hepatitis-C virus (HCV) infection. The screening data of antibody to HCV (anti-HCV) and of hepatitis-B virus antigen (HBsAg) in 111,069 male blood-donors, and the incidence data of male PLC obtained from the Osaka Cancer Registry were examined. In a multiple-weighted regression analysis, the age-standardized incidence rate of PLC in the 61 counties within Osaka was correlated significantly with the age-standardized prevalence of anti-HCV with adjustment for that of HBsAg (regression coefficient [RC] = 7.26, P < 0.0001). This finding was consistent with the relationship between the PLC incidence rate and the prevalence of high-titer (> or = 2(12)) anti-HCV (RC = 11.18, P < 0.0001). There was significant association between the prevalence of HBsAg and the PLC incidence rate with adjustment for that of anti-HCV (RC = 7.08, P = 0.018). These findings suggest that the PLC-incidence variation within Osaka is correlated with the geographic pattern of HCV infection as well as that of HBV infection among the residents.

摘要

日本大阪是世界上原发性肝癌(PLC)发病率最高的地区之一,尽管乙肝病毒(HBV)并非地方流行性病原体。本文探讨了大阪府内PLC发病率的差异是否归因于丙型肝炎病毒(HCV)感染率的不同。研究人员检查了111,069名男性献血者的HCV抗体(抗-HCV)和乙肝病毒抗原(HBsAg)的筛查数据,以及从大阪癌症登记处获得的男性PLC发病率数据。在多元加权回归分析中,大阪61个县内PLC的年龄标准化发病率与抗-HCV的年龄标准化患病率显著相关,并对HBsAg的患病率进行了校正(回归系数[RC]=7.26,P<0.0001)。这一发现与PLC发病率和高滴度(≥2(12))抗-HCV患病率之间的关系一致(RC=11.18,P<0.0001)。在对抗-HCV患病率进行校正后,HBsAg患病率与PLC发病率之间存在显著关联(RC=7.08,P=0.018)。这些发现表明,大阪府内PLC发病率的差异与居民中HCV感染的地理分布模式以及HBV感染的地理分布模式相关。

相似文献

1
Primary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan.丙型肝炎病毒感染相关的原发性肝癌发病率:日本大阪的一项相关性研究。
Cancer Causes Control. 1994 Jan;5(1):61-5. doi: 10.1007/BF01830727.
2
Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.日本大阪地区无偿献血者中丙型肝炎病毒第二代抗体的流行情况。
Cancer Causes Control. 1994 Sep;5(5):409-13. doi: 10.1007/BF01694754.
3
Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan.孟加拉国和日本献血者丙型肝炎血清流行病学比较。
Gastroenterol Jpn. 1993 May;28 Suppl 5:28-31. doi: 10.1007/BF02989200.
4
High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.日本肝细胞癌患者中乙肝和丙肝病毒标志物的高流行率。
Gastroenterol Jpn. 1993 Aug;28(4):547-53. doi: 10.1007/BF02776954.
5
The role of hepatitis C virus in chronic hepatitis B virus infection.丙型肝炎病毒在慢性乙型肝炎病毒感染中的作用。
Gastroenterol Jpn. 1993 May;28 Suppl 5:23-7. doi: 10.1007/BF02989199.
6
Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.台湾农村肝癌高流行地区乙肝携带者或丙肝抗体阳性者的危险因素差异。
J Clin Epidemiol. 1998 Sep;51(9):733-8. doi: 10.1016/s0895-4356(98)00060-2.
7
Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.关于丙型肝炎病毒阳性献血者肝细胞癌风险的前瞻性研究,重点关注人口统计学因素、献血时的丙氨酸转氨酶水平以及与乙型肝炎病毒的相互作用。
Int J Cancer. 2004 Dec 20;112(6):1075-80. doi: 10.1002/ijc.20507.
8
Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin.以色列献血者中抗丙型肝炎抗体和乙型肝炎表面抗原流行率按年龄、性别、出生国家和原籍划分的种族差异。
J Viral Hepat. 1995;2(3):139-44. doi: 10.1111/j.1365-2893.1995.tb00019.x.
9
Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).吉尔吉斯斯坦献血者中乙型肝炎、丙型肝炎、人类免疫缺陷病毒、梅毒螺旋体及合并感染的血清流行率:一项回顾性分析(2013 - 2015年)
Infect Dis Poverty. 2017 Feb 21;6(1):45. doi: 10.1186/s40249-017-0255-9.
10
Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.在乙型肝炎感染呈高度地方性流行的埃塞俄比亚,丙型肝炎病毒感染与慢性肝病
Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):171-4. doi: 10.1016/0035-9203(95)90482-4.

引用本文的文献

1
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.丙型肝炎病毒感染可能是肝内胆管癌的病因。
Cancer Sci. 2004 Jul;95(7):592-5. doi: 10.1111/j.1349-7006.2004.tb02492.x.
2
Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.丙型肝炎病毒携带者肝细胞癌的累积风险:基于横断面数据的统计估计
Jpn J Cancer Res. 1994 May;85(5):485-90. doi: 10.1111/j.1349-7006.1994.tb02384.x.
3
Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.

本文引用的文献

1
Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.病毒血症证实的丙型肝炎病毒持续感染筛查试验的预测价值。日本的经验。
Vox Sang. 1993;65(3):199-203. doi: 10.1111/j.1423-0410.1993.tb02148.x.
2
Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong.乙型肝炎病毒与吸烟:香港肝细胞癌的危险因素
Cancer Res. 1982 Dec;42(12):5246-8.
3
Smoking and hepatitis B-negative primary hepatocellular carcinoma.吸烟与乙肝阴性原发性肝细胞癌
日本大阪地区无偿献血者中丙型肝炎病毒第二代抗体的流行情况。
Cancer Causes Control. 1994 Sep;5(5):409-13. doi: 10.1007/BF01694754.
J Natl Cancer Inst. 1980 Jul;65(1):111-4.
4
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.肝细胞癌与乙型肝炎病毒。对台湾22707名男性的前瞻性研究。
Lancet. 1981 Nov 21;2(8256):1129-33. doi: 10.1016/s0140-6736(81)90585-7.
5
Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.慢性非甲非乙型输血后肝炎引发的原发性肝细胞癌
Ann Intern Med. 1984 Dec;101(6):794-5. doi: 10.7326/0003-4819-101-6-794.
6
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.非甲非乙型输血后肝炎所致肝细胞癌
Am J Gastroenterol. 1984 Oct;79(10):777-81.
7
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.莫桑比克和特兰斯凯的肝细胞癌与膳食黄曲霉毒素
Br J Cancer. 1985 May;51(5):713-26. doi: 10.1038/bjc.1985.107.
8
Relationship between hepatitis B surface antigen prevalence, per capita alcohol consumption and primary liver cancer death rate in 30 countries.
J Clin Epidemiol. 1988;41(8):787-92. doi: 10.1016/0895-4356(88)90165-5.
9
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.从经血传播的非甲非乙型病毒性肝炎基因组中分离出一个cDNA克隆。
Science. 1989 Apr 21;244(4902):359-62. doi: 10.1126/science.2523562.
10
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.一种针对人类非甲非乙型肝炎主要致病病毒的循环抗体检测方法。
Science. 1989 Apr 21;244(4902):362-4. doi: 10.1126/science.2496467.